Moreover, understanding the genomic and molecular pathogenesis of NF2 variants will provide insights into better knowledge about tumorigenesis-related manifestations, such as meningioma, spinal schwannomas, ependymomas, and dermal schwannomas [25]. The gene discussed is NF2; the disease is ependymoma.